Advertisement

Primary Colorectal Cancer

Published:November 03, 2022DOI:https://doi.org/10.1016/j.soc.2022.08.002

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Phillips E.H.
        • Franklin M.
        • Carroll B.J.
        • et al.
        Laparoscopic colectomy.
        Ann Surg. 1992; 216: 703-707
        • Lacy A.M.
        • García-Valdecasas J.C.
        • Delgado S.
        • et al.
        Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial.
        Lancet. 2002; 359: 2224-2229
        • Buunen M.
        • Veldkamp R.
        • Hop W.C.
        • et al.
        Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.
        Lancet Oncol. 2009; 10: 44-52
        • Nelson H.
        • Sargent D.J.
        • Wieand H.S.
        • et al.
        A comparison of laparoscopically assisted and open colectomy for colon cancer.
        N Engl J Med. 2004; 350: 2050-2059
        • Fleshman J.
        • Sargent D.J.
        • Green E.
        • et al.
        Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.
        Ann Surg. 2007; 246 ([discussion: 662-4]): 655-662
        • Krane M.K.
        • Fichera A.
        Laparoscopic rectal cancer surgery: where do we stand?.
        World J Gastroenterol. 2012; 18: 6747-6755
        • Guillou P.J.
        • Quirke P.
        • Thorpe H.
        • et al.
        Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.
        Lancet. 2005; 365: 1718-1726
        • van der Pas M.H.
        • Haglind E.
        • Cuesta M.A.
        • et al.
        Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.
        Lancet Oncol. 2013; 14: 210-218
        • Fleshman J.
        • Branda M.
        • Sargent D.J.
        • et al.
        Effect of laparoscopic-assisted resection vs open resection of stage ii or iii rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial.
        JAMA. 2015; 314: 1346-1355
        • Fleshman J.
        • Branda M.E.
        • Sargent D.J.
        • et al.
        Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial.
        Ann Surg. 2019; 269: 589-595
        • Stevenson A.R.
        • Solomon M.J.
        • Lumley J.W.
        • et al.
        Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial.
        JAMA. 2015; 314: 1356-1363
        • Kang S.B.
        • Park J.W.
        • Jeong S.Y.
        • et al.
        Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial.
        Lancet Oncol. 2010; 11: 637-645
        • Jayne D.
        • Pigazzi A.
        • Marshall H.
        • et al.
        Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical Trial.
        JAMA. 2017; 318: 1569-1580
        • Kim M.J.
        • Park S.C.
        • Park J.W.
        • et al.
        Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial.
        Ann Surg. 2018; 267: 243-251
        • Kapiteijn E.
        • Marijnen C.A.
        • Nagtegaal I.D.
        • et al.
        Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.
        N Engl J Med. 2001; 345: 638-646
        • van Gijn W.
        • Marijnen C.A.
        • Nagtegaal I.D.
        • et al.
        Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
        Lancet Oncol. 2011; 12: 575-582
        • Sauer R.
        • Becker H.
        • Hohenberger W.
        • et al.
        Preoperative versus postoperative chemoradiotherapy for rectal cancer.
        N Engl J Med. 2004; 351: 1731-1740
        • Sauer R.
        • Liersch T.
        • Merkel S.
        • et al.
        Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.
        J Clin Oncol. 2012; 30: 1926-1933
        • Ngan S.Y.
        • Burmeister B.
        • Fisher R.J.
        • et al.
        Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
        J Clin Oncol. 2012; 30: 3827-3833
        • Erlandsson J.
        • Lörinc E.
        • Ahlberg M.
        • et al.
        Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial.
        Radiother Oncol. 2019; 135: 178-186
        • Erlandsson J.
        • Holm T.
        • Pettersson D.
        • et al.
        Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
        Lancet Oncol. 2017; 18: 336-346
        • Bahadoer R.R.
        • Dijkstra E.A.
        • van Etten B.
        • et al.
        Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
        Lancet Oncol. 2021; 22: 29-42
        • Garcia-Aguilar J.
        • Chow O.S.
        • Smith D.D.
        • et al.
        Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
        Lancet Oncol. 2015; 16: 957-966
        • Conroy T.
        • Bosset J.F.
        • Etienne P.L.
        • et al.
        Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
        Lancet Oncol. 2021; 22: 702-715
        • Habr-Gama A.
        • Perez R.O.
        • Nadalin W.
        • et al.
        Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.
        Ann Surg. 2004; 240 ([discussion: 717-8]): 711-717
        • Habr-Gama A.
        • São Julião G.P.
        • Vailati B.B.
        • et al.
        Organ preservation among patients with clinically node-positive rectal cancer: is it really more dangerous?.
        Dis Colon Rectum. 2019; 62: 675-683
        • Rullier E.
        • Vendrely V.
        • Asselineau J.
        • et al.
        Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
        Lancet Gastroenterol Hepatol. 2020; 5: 465-474
        • van der Valk M.J.M.
        • Hilling D.E.
        • Bastiaannet E.
        • et al.
        Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
        Lancet. 2018; 391: 2537-2545
        • Garcia-Aguilar J.
        • Patil S.
        • Gollub M.J.
        • et al.
        Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
        J Clin Oncol. 2022; 40: 2546-2556
        • Jeong W.J.
        • Choi B.J.
        • Lee S.C.
        Pure natural orifice transluminal endoscopic surgery for rectal cancer: Ta-TME and CME without abdominal assistance.
        Asian J Surg. 2019; 42: 450-457
        • Marks J.H.
        • Salem J.F.
        • Adams P.
        • et al.
        initial clinical experience with single-port robotic transanal total mesorectal excision (SP rTaTME).
        Tech Coloproctol. 2021; 25: 721-726
        • Zorron R.
        • Phillips H.N.
        • Wynn G.
        • et al.
        "Down-to-Up" transanal NOTES Total mesorectal excision for rectal cancer: Preliminary series of 9 patients.
        J Minim Access Surg. 2014; 10: 144-150
        • Rasulov A.O.
        • Mamedli Z.Z.
        • Dzhumabaev K.E.
        • et al.
        [Total mesorectal excision in rectal cancer management: laparoscopic or transanal?].
        Khirurgiia (Mosk). 2016; : 37-44
        • Zeng Z.
        • Luo S.
        • Chen J.
        • et al.
        Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.
        Surg Endosc. 2020; 34: 3956-3962
        • Deijen C.L.
        • Velthuis S.
        • Tsai A.
        • et al.
        COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
        Surg Endosc. 2016; 30: 3210-3215
        • Serra-Aracil X.
        • Zárate A.
        • Mora L.
        • et al.
        Study protocol for a multicenter prospective controlled and randomized trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer.
        Int J Colorectal Dis. 2018; 33: 649-655